Ascent Group, LLC Insulet Corp Transaction History

Ascent Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$276.36 - $326.03 $4,421 - $5,216	16 Added 1.64%	990 $315,000
Q4 2022 Feb 16, 2023	BUY	$212.22 - $313.46 $2,122 - $3,134	10 Added 1.04%	974 $286,000
Q3 2022 Nov 14, 2022	BUY	$224.6 - $281.45 $898 - $1,125	4 Added 0.42%	964 $249,000
Q2 2022 Aug 05, 2022	BUY	$186.4 - $279.02 $21,436 - $32,087	115 Added 13.61%	960 $238,000
Q1 2022 May 10, 2022	BUY	$194.8 - $275.7 $164,606 - $232,966	845 New	845 $225,000

752

63.2M

475K

639K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $19.5B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Ascent Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Ascent Group, LLC with notifications on news.